PharmacyCodes



Enteropride en es it fr

Enteropride Brand names, Enteropride Analogs

Enteropride Brand Names Mixture

  • No information avaliable

Enteropride Chemical_Formula

C23H29ClFN3O4

Enteropride RX_link

http://www.rxlist.com/cgi/generic/cisap.htm

Enteropride fda sheet

Enteropride msds (material safety sheet)

Enteropride MSDS

Enteropride Synthesis Reference

No information avaliable

Enteropride Molecular Weight

465.945 g/mol

Enteropride Melting Point

110 oC

Enteropride H2O Solubility

2.71 mg/L

Enteropride State

Solid

Enteropride LogP

3.802

Enteropride Dosage Forms

Suspension; Tablet

Enteropride Indication

For the symptomatic treatment of adult patients with nocturnal heartburn due to gastroesophageal reflux disease.

Enteropride Pharmacology

Cisapride is a parasympathomimetic which acts as a serotonin 5-HT4 agonist. Stimulation of the serotonin receptors increases acetylcholine release in the enteric nervous system. Cisapride stimulates motility of the upper gastrointestinal tract without stimulating gastric, biliary, or pancreatic secretions. Cisapride increases the tone and amplitude of gastric (especially antral) contractions, relaxes the pyloric sphincter and the duodenal bulb, and increases peristalsis of the duodenum and jejunum resulting in accelerated gastric emptying and intestinal transit. It increases the resting tone of the lower esophageal sphincter. It has little, if any, effect on the motility of the colon or gallbladder. Cisapride does not induce muscarinic or nicotinic receptor stimulation, nor does it inhibit acetylcholinesterase activity.

Enteropride Absorption

Cisapride is rapidly absorbed after oral administration, with an absolute bioavailability of 35-40%.

Enteropride side effects and Toxicity

No information avaliable

Enteropride Patient Information

No information avaliable

Enteropride Organisms Affected

Humans and other mammals